相关实验视频
Updated: Jun 14, 2025

05:44
Ultrasonographic Evaluation of Breast Cancer-related Lymphedema
Published on: January 12, 2017
10.0K
身体活动和表观遗传衰老在乳腺癌治疗中的作用
Chantalle Moulton1, Elisa Grazioli2, José Santiago Ibáñez-Cabellos3,4
1Unit of Biology and Genetics of Movement, Department of Movement, Human and Health Sciences, University of Rome Foro Italico, 00135 Rome, Italy.
International journal of molecular sciences
|August 29, 2024
概括
这项研究表明,16周的体力活动 (PA) 干预可以减少乳腺癌幸存者的生物年龄. 生物年龄的减少与身体健康和力量的改善相关,有助于恢复.
科学领域:
- 老年学是一门学科.
- 在瘤学瘤学.
- 运动科学 运动科学
背景情况:
- 生物年龄,衡量累积的身体损伤,是比时间年龄更好的健康指标.
- 加速衰老与不良结果有关,特别是在接受治疗的乳腺癌 (BC) 幸存者中.
- 正在探索体育活动 (PA) 干预措施,以缓解临床人群的衰老过程.
研究的目的:
- 为了研究16周在线监督的PA干预对手术后女性BC患者生物年龄的影响.
- 评估PA干预后的端粒长度和ELOVL2表观遗传钟的变化.
- 探索生物年龄变化与身体健康和力量的改善之间的关联.
主要方法:
- 参与者:手术后的女性乳腺癌患者.
- 干预:为期16周的在线监督体育活动计划.
- 测量:端粒长度 (qPCR),ELOVL2表观遗传时钟 (DNA甲基化热测序),心血管健康和手握强度.
主要成果:
- 端粒长度没有显著变化.
- ELOVL2表观遗传时钟显示,PA组的生物年龄显著下降.
- 降低生物年龄与改善的心血管健康和手握强度相关.
结论:
- 16周的PA干预可以逆转BC幸存者的加速衰老,正如ELOVL2表观遗传钟所指出的那样.
- 表观遗传钟为评估BC患者的健康状况和康复提供了一个潜在的工具.
- 通过PA的干预,可以改善BC手术后幸存者的整体健康和康复.
相关概念视频
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

